By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GE Healthcare company Clarient and Acorn Research today announced a collaboration targeting the molecular testing of tumor samples.

The collaboration, the terms of which were not disclosed, brings together Clarient's expertise in cancer diagnostics and Acorn's oncology network and advanced bioinformatics platform, they said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Scientific Reports editor resigns over a new policy at the journal allowing researchers to pay to fast track the peer review of their manuscripts, and poll.

The National Cancer Institute's Harold Varmus discusses the state of cancer research with the New York Times.

In PNAS this week: rare variants linked to bleeding disorder, comparison of whole-exome and whole-genome sequencing, and more.

George Church tells The Sunday Times that his group has inserted some woolly mammoth genes into elephant cells.